Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

KRTAP12-4 Inhibitors

KRTAP12-4 inhibitors are chemical compounds that target and inhibit the activity of keratin-associated protein 12-4 (KRTAP12-4). This protein is a member of the keratin-associated protein (KAP) family, which plays a crucial role in the structural integrity of keratin fibers. Keratin fibers are essential components of hair, nails, and other epithelial structures, and KRTAP12-4 specifically interacts with keratin intermediate filaments to modulate their assembly and stabilization. By inhibiting KRTAP12-4, these inhibitors can alter the behavior of keratin filaments, potentially leading to changes in their structural organization, mechanical properties, or overall function. KRTAP12-4 inhibitors are typically designed to interfere with the binding sites or conformational changes required for KRTAP12-4 to associate with keratin filaments.

The molecular structure of KRTAP12-4 inhibitors often includes elements that allow them to selectively bind to the KRTAP12-4 protein, disrupting its normal interactions with keratin proteins. These compounds may possess a variety of chemical scaffolds, including small organic molecules, peptides, or other biologically derived structures. The specificity of KRTAP12-4 inhibitors is critical, as targeting KRTAP proteins requires precise molecular recognition to avoid affecting other members of the keratin family or associated proteins. Research into KRTAP12-4 inhibitors often focuses on understanding how inhibition of this protein affects the biochemical properties of keratin-based structures and the molecular pathways involved in keratin regulation. Detailed structural studies of KRTAP12-4 and its interactions with inhibitors are essential to uncover how these compounds exert their effects at the molecular level.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This cytidine analogue could lead to the hypomethylation of the KRTAP12-4 gene promoter, resulting in the downregulation of its mRNA synthesis.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A may prevent the deacetylation of histones associated with the KRTAP12-4 gene, thereby repressing the initiation of its transcription.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
19
(3)

Sodium Butyrate could decrease KRTAP12-4 expression by inducing a more condensed chromatin structure around the gene, limiting transcriptional activity.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Suberoylanilide Hydroxamic Acid may directly inhibit the expression of KRTAP12-4 by maintaining histones in an acetylated state, which can repress gene transcription.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

RG 108 could reduce the expression of KRTAP12-4 by blocking the methylation of cytosine residues within its promoter region, leading to transcriptional silencing.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

5-Aza-2′-Deoxycytidine could decrease KRTAP12-4 levels by incorporating into DNA during replication and irreversibly inhibiting DNA methyltransferase, leading to promoter demethylation.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

By binding to the DNA in the control regions of the KRTAP12-4 gene, Mithramycin A could inhibit the binding of transcription factors necessary for its transcription.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic Acid may repress the transcription of KRTAP12-4 by activating retinoic acid receptors that interfere with the promoter activity of the gene.

Spironolactone

52-01-7sc-204294
50 mg
$107.00
3
(1)

Spironolactone could indirectly downregulate KRTAP12-4 expression by antagonizing aldosterone, which may alter the hormonal balance controlling hair follicle gene expression.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

Hydroxyurea may reduce KRTAP12-4 expression by disrupting the DNA replication process, which can lead to a nonspecific decrease in gene expression, including that of KRTAP12-4.